How Much Does TRT Cost? The Price of Testosterone Therapy in Poland [2026]
What does testosterone replacement therapy actually cost in Poland? We break the expense down into its components — diagnostics, consultations, medication (injections vs. gel), and monitoring — and explain why, for most men, TRT is in practice a private, out-of-pocket service rather than something covered by public health insurance.
Number of studies
2
Safety
Requires caution
Time to effects
Not applicable to clinical effects — this piece is a price orientation. Time to subjective improvement after starting testosterone therapy is covered in our entry on TRT delivery forms.
Who it's for
Table of contents
TL;DR
What does testosterone replacement therapy actually cost in Poland? We break the expense down into its components — diagnostics, consultations, medication (injections vs. gel), and monitoring — and explain why, for most men, TRT is in practice a private, out-of-pocket service rather than something covered by public health insurance.
- →Lets you realistically plan a budget before starting therapy, instead of being blindsided by costs a few months in
- →Reveals that the delivery form (generic injections vs. gel vs. long-acting undecanoate) can differ in monthly cost by several times
- →Helps you assess whether a given clinic or physician is overcharging relative to market rates for consultations and tests
| Initial diagnostics (one-time) | approx. 150–450 PLN for the hormone panel + additional tests (PSA, complete blood count, lipid panel) |
|---|---|
| Qualifying consultation (endocrinologist/urologist) | approx. 150–450 PLN per visit; often 2 visits are needed before starting |
| Medication per month — generic injections (enanthate) | approx. 45–100 PLN/month |
| Medication per month — long-acting injections (undecanoate, e.g., Nebido) | approx. 130–240 PLN/month (vial cost spread over a 10–14 week cycle) |
| Medication per month — transdermal gel | approx. 150–380 PLN/month, depending on dose and package size |
| Annual monitoring (tests + follow-up visits) | approx. 800–2,000 PLN/year with 2–4 check-ups a year |
| Coverage under public insurance (NFZ) | Very limited — in practice, most men pay privately for the medication and most visits |
| Estimated total cost — first year | approx. 2,500–7,500 PLN, depending on the drug form and check-up frequency |
| Estimated total cost — subsequent years | approx. 1,500–6,500 PLN/year (excluding the one-time initial diagnostics) |
Understand
Overview
Testosterone replacement therapy (TRT) in Poland is, in the vast majority of cases, an out-of-pocket expense — not because it's an experimental or unproven treatment, but because Poland's public health insurance (NFZ) doesn't broadly cover any of the available testosterone preparations. As a result, a man who qualifies for TRT has to budget for several independent line items: initial diagnostics, a specialist consultation confirming the indication, recurring purchases of the medication, and regular follow-up tests for the entire duration of treatment — treatment that, once started, is effectively lifelong.
The total cost depends heavily on the chosen delivery form of testosterone. Injections with a generic ester (testosterone enanthate) are among the cheapest options on a monthly basis; long-acting testosterone undecanoate (Nebido) has a higher per-vial cost, partly offset by less frequent dosing; and transdermal gels — despite requiring daily application of small amounts — can end up costing similarly to or more than the pricier injections when calculated per month. On top of that comes a cost many men forget in their first calculation: regular blood tests, without which safely running therapy for years simply isn't possible.
This piece isn't financial advice or a guarantee of any specific price — it's an orientational guide to real price ranges current as of August 2026, gathered from Polish pharmacy price-comparison sites (Gdzie po lek, Apteline, KtoMaLek), diagnostic lab price lists, and private specialist consultation fees. Prices for medications, visits, and tests change over time, vary between regions and facilities, and pharmacy promotions can shift a figure from one day to the next — treat the ranges given here as a starting point for your own calculation, not a guaranteed price list. The decision to start TRT and the choice of a specific clinic should always be made with your treating physician, taking into account your individual health, not price alone.
History of use
Testosterone replacement therapy has been available in Poland for decades, but — unlike, say, insulin or cardiac medications — it has never received broad NFZ reimbursement. The market remains largely a private one: patients buy the medication at a pharmacy on a specialist's prescription, and most often pay for diagnostics and consultations out of pocket or through a private health plan. This sets the Polish model apart from some Western European countries with more developed public financing pathways for male hormone replacement therapy.
Mechanism of action
TRT's cost structure follows directly from the nature of the therapy: it isn't a one-time intervention, but a pharmacological suppression of the body's own hypothalamic-pituitary-gonadal axis that has to be sustained essentially for life. Administering exogenous testosterone suppresses LH and FSH secretion through negative feedback, which limits the testes' own hormone production — abruptly stopping therapy without appropriate medical management leads to a period of secondary testosterone deficiency, often subjectively worse than the pre-treatment baseline. That's why a TRT budget needs to be planned not as a single expense, but as a recurring monthly and annual cost stretched over years.
The total cost is made up of four independent expense streams that combine in different proportions depending on the chosen treatment path: one-time qualifying diagnostics, recurring physician consultations, ongoing purchases of medication (whose price varies significantly by delivery form and dosing frequency), and regular blood monitoring, essential for safely running therapy for years — including assessment of hematocrit, PSA, and testosterone concentration itself. Endocrine Society guidelines clearly identify monitoring as an integral, mandatory part of therapy, not an optional add-on — which has a direct budgetary consequence: leaving this element out of the calculation is the most common mistake people planning TRT make, counting only the cost of the medication while overlooking regular follow-up tests, which over the course of a year add a cost comparable to the medication itself — and with cheaper forms of therapy, sometimes even higher.
Diagnostics and qualification
A hormone test panel (testosterone, LH, FSH, SHBG) and a specialist consultation confirming hypogonadism — a one-time cost incurred before therapy even starts.
Choosing a drug form and the first purchase
Monthly cost depends heavily on the form: generic enanthate injections are usually cheapest, while gels and long-acting undecanoate (Nebido) cost more per month.
Follow-up at 3 and 6 months
The first follow-up blood tests assess treatment response and safety — hematocrit, PSA, testosterone concentration — generating another recurring cost.
Routine long-term monitoring
Once the dose is stabilized, check-ups usually happen every 6–12 months for the entire duration of therapy — essentially for life.
Evidence: moderate — based on 2 studies in this database.
Benefits
Common myths
MythTRT in Poland is reimbursed by NFZ like most chronic-disease medications.
FactCurrently, no testosterone preparation has broad NFZ reimbursement. The public pathway is narrow, requires documented hypogonadism, and involves long waits — in practice most patients pay privately for the medication itself and for most visits.
MythGel is always more expensive than injections because it has to be applied daily.
FactIt depends on the specific product. Generic testosterone enanthate injections are often one of the cheapest monthly options on the Polish market, while some gels fall in a similar price range to pricier long-acting injections like Nebido.
MythThe medication itself is the biggest cost of TRT.
FactOver the course of a year, the combined cost of regular consultations and follow-up tests can be comparable to the cost of the medication — and with cheaper forms of therapy, even higher than the drug itself.
Forms & variants
How Much Does TRT Cost? The Price of Testosterone Therapy in Poland [2026] comes in several forms that differ in bioavailability and use case — the form you pick genuinely matters for how effective the supplementation is.
Short-acting injections — testosterone enanthate/cypionate
Generic esters given every 1–2 weeks. One of the cheapest monthly options on the Polish pharmacy market, with a package cost of roughly 90–255 PLN for 5 ampoules.
Best for: Patients looking for the lowest monthly cost, willing to accept more frequent injections and fluctuating concentrations across the dosing cycle
Long-acting injections — testosterone undecanoate (Nebido)
Less frequent dosing (every 10–14 weeks) at a higher per-vial price (approx. 380–720 PLN), which, spread across the full cycle, works out to a higher monthly cost than generic enanthate.
Best for: Patients who value less frequent dosing visits and are willing to accept a higher monthly cost in exchange for convenience
Transdermal gel (Androgel, Testogel, Androtop, and similar)
Daily application, with a monthly cost close to the pricier long-acting injections — roughly 150–380 PLN for a monthly package, depending on dose and brand.
Best for: Patients who prefer a steadier daily profile and are willing to pay a higher monthly cost than with generic injections
Transdermal patches
Rarely used in Poland today due to frequent skin irritation and limited availability — usually the most expensive and least practical option on this list.
Best for: Rarely the first choice in modern clinical or budgetary practice
Practice
Frequently asked questions
In practice, only to a very limited extent. No testosterone preparation currently has broad NFZ reimbursement on par with chronic-disease medications like insulin. A public pathway exists, but it requires confirmed, documented hypogonadism, comes with waits for a specialist, and usually still ends with a prescription filled entirely out of pocket at the pharmacy. For most men, TRT in Poland remains a private-pay service.
Usually generic testosterone enanthate injections (e.g., Testosteronum Prolongatum Jelfa), which run roughly 45–100 PLN a month. Long-acting undecanoate (Nebido) and transdermal gels are typically more expensive, though the differences depend on the exact dose and pharmacy.
A basic hormone panel (testosterone, LH, FSH, SHBG) is roughly 110–190 PLN. Once you add the extra tests recommended before qualification — complete blood count, lipid panel, PSA — the total usually falls in the 150–450 PLN range, depending on the lab and panel scope.
An endocrinology consultation in larger cities usually costs 250–450 PLN, with online offers starting around 150 PLN. A urology visit falls in a similar range, roughly 250–360 PLN. Qualification often requires two visits — an initial diagnostic one and a follow-up to discuss results.
Adding up the one-time diagnostics, the qualifying consultation, 12 months of medication (depending on the chosen form), and regular follow-up tests, a realistic range for the first year is roughly 2,500–7,500 PLN. Subsequent years, without the one-time initial costs, are usually cheaper — roughly 1,500–6,500 PLN a year.
Not necessarily. The price difference between generic enanthate and Nebido or gel mainly comes from dosing frequency, release technology, and brand, not from differences in clinical efficacy at a properly chosen dose. The choice of form should primarily consider tolerance, convenience, and your physician's recommendation, with price a secondary factor.
We strongly advise against it. Buying testosterone outside the legal pharmacy system means no quality control, a risk of counterfeit or incorrectly dosed product, and no medical oversight of therapy safety — any potential savings don't offset that health risk.
It depends on the specific plan — some cover an endocrinology or urology consultation, but rarely include the medication itself or the full scope of follow-up testing. It's worth checking the detailed coverage of your own plan before assuming any budget savings.
Dosage & timing
Typical dose
Not applicable to pharmacological dosing — this piece describes the cost of therapy, not a treatment regimen (see the fact sheet and variants below for a price breakdown)
Form
Cost differs by form: injections (every 1–4 weeks, depending on the ester), transdermal gel (daily application)
The actual dose and frequency — and therefore the final monthly cost — are set individually by the physician based on blood results; there's no single universal figure for all patients.
Best times to take it
- Initial diagnostics and the first qualifying consultation — one-time, before starting therapy
- Follow-up blood tests — usually at 3 and 6 months after starting treatment, then typically every 6–12 months
- Medication purchases — recurring, depending on form: every 1–2 weeks for short-acting injections, every 10–14 weeks for undecanoate (Nebido), daily for gel
Safety
Side effects & contraindications
Possible side effects
Costs of treating side effects of therapy (e.g., more frequent phlebotomies for excessive erythrocytosis, additional cardiology consultations) not included in the base drug price
Cost of adjunct medications used in some protocols (e.g., hCG to preserve fertility, aromatase inhibitors) — a separate budget line
Risk of overpaying at clinics offering opaque 'all-inclusive' packages without a breakdown of individual costs
The recurring cost of time — regular visits and follow-up tests require ongoing commitment over a long, multi-year horizon, not just a one-time effort
Contraindications
No confirmed hypogonadism — spending money on TRT without a proper differential diagnosis has no clinical or economic justification
The possibility of reversing the cause of low testosterone through cheaper means (weight loss, treating sleep apnea, reducing chronic stress) instead of lifelong pharmacotherapy
Near-term plans to have children without first discussing TRT's impact on fertility and the potential added cost of protecting it
Buying testosterone outside the legal healthcare system to cut costs — no quality control, dosing accuracy, or safety oversight, a serious health risk that outweighs any potential savings
Interactions
Private medical plans (employer benefits) sometimes cover an endocrinology or urology consultation, but rarely reimburse the medication itself — worth checking the scope of your specific plan before assuming savings
Sports cards and wellness packages usually don't cover hormone-related visits or lab tests associated with TRT
Buying the medication in larger packages (e.g., Nebido spread over a longer cycle) can be cheaper per month than buying smaller quantities of other preparations more frequently
Is it worth taking?
Who it's for
- Men considering starting TRT who want to realistically estimate their budget before deciding
- Patients already in the qualification process, comparing offers and price lists from different clinics and physicians
- People weighing the difference between the public (NFZ) pathway and fully private treatment
Not for
- No confirmed hypogonadism — spending money on TRT without a proper differential diagnosis has no clinical or economic justification
- The possibility of reversing the cause of low testosterone through cheaper means (weight loss, treating sleep apnea, reducing chronic stress) instead of lifelong pharmacotherapy
- Near-term plans to have children without first discussing TRT's impact on fertility and the potential added cost of protecting it
- Buying testosterone outside the legal healthcare system to cut costs — no quality control, dosing accuracy, or safety oversight, a serious health risk that outweighs any potential savings
Evidence
Worth knowing
A vial of Nebido (testosterone undecanoate) costs roughly 380–720 PLN in Polish pharmacies, depending on the pharmacy and region (data: August 2026, gdziepolek.pl/apteline.pl).
Testosteronum Prolongatum Jelfa (enanthate) — one of the cheaper injectable options available in Poland — costs roughly 90–255 PLN for a package of 5 ampoules.
A private endocrinology consultation in larger cities typically runs 250–450 PLN per visit, though offers from around 150 PLN exist, and online consultations start at around 149 PLN.
A basic hormone panel (testosterone, LH, FSH, SHBG) at commercial labs costs roughly 110–190 PLN, depending on the city and lab network.
Studies
Testosterone therapy requires careful, long-term safety monitoring — including regular assessment of hematocrit, PSA, and clinical symptoms — throughout the entire course of treatment, not just in the first months.
Bhasin S et al. (Endocrine Society guideline), Journal of Clinical Endocrinology & Metabolism, 2018
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline
Strong evidenceBhasin S, Brito JP, Cunningham GR, et al. · Journal of Clinical Endocrinology & Metabolism · 2018
The Endocrine Society clinical guideline defining, among other things, the requirements for regular, long-term safety monitoring of testosterone therapy — the basis for the recurring monitoring cost described in this piece.
View studyEffects of Testosterone Treatment in Older Men (The Testosterone Trials)
Strong evidenceSnyder PJ, Bhasin S, Cunningham GR, et al. · New England Journal of Medicine · 2016
A set of randomized trials (the Testosterone Trials) confirming that the benefits of testosterone therapy persist with continuous treatment — supporting the case for planning TRT as a long-term cost rather than a one-time expense.
View studySources & bibliography
- Bhasin et al. 2018 — Endocrine Society Guideline
- Nebido — pharmacy prices across Poland (Gdzie po lek)
- Testosteronum Prolongatum Jelfa — pharmacy prices (Gdzie po lek)
- Endocrinology visit pricing 2026 (kb.pl)
- Urology visit pricing 2026 (kb.pl)
- Male hormone test panels — ALAB laboratories
Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.
Compare with similar entries
About the authors of this entry
Author
dr Piotr ZielińskiEndocrinologist
Piotr reviews content on hormones, metabolic health and supplement pharmacology.
131 publications on this site
Medical review
dr Anna KowalczykEditor-in-Chief, Molecular Biology
Anna oversees the editorial process and scientific review of every publication in the knowledge base. She previously researched autophagy and mitochondrial biology.
50 publications on this site
Related entries
4.4TRT — Administration Forms: Injections, Gels, and Patches
Injections, transdermal gels, and patches — the three main forms of testosterone replacement therapy differ in blood-concentration profile, ease of use, and the risk of transferring the hormone to other people.
4.6Hypogonadism — Diagnosis and Criteria for TRT Eligibility
Not every low testosterone result means hypogonadism requiring treatment. We explain which laboratory and symptomatic criteria must be met before TRT becomes a justified option.
4.7What Tests Are Needed Before TRT? The Complete Pre-Treatment Testing List
Before a physician can qualify a patient for testosterone therapy, a far broader panel of tests is needed than testosterone level alone. The full list of blood tests, symptom questionnaires, and criteria that determine whether TRT is safe and appropriate.
4.7TRT (Testosterone Replacement Therapy) — What Is It and Who Is It For?
TRT isn't a supplement for fatigue — it's pharmacological treatment for a confirmed testosterone deficiency, with a real but limited list of benefits and an equally real list of people who simply don't qualify for it.
4.7TRT — Side Effects and Therapy Monitoring
Erythrocytosis, fertility impact, PSA screening, and the cardiovascular risk question — what testosterone replacement therapy safety actually involves and how it's monitored.
4.7How Often to Test Testosterone on TRT? Monitoring Schedule and Checkups
Starting testosterone therapy isn't the end of diagnostics — it's the start of a new, recurring rhythm of checkups. We explain which tests happen at month 3, which at year one, and which need repeating for as long as therapy continues — and how the schedule differs between injectable and gel forms.
4.7TRT and Your Heart — Does Testosterone Therapy Raise Heart Attack Risk?
For a decade, testosterone therapy operated under the shadow of an FDA warning about heart attack risk. The large randomized TRAVERSE trial from 2023 finally gave a clear answer — though not as simple as the headlines suggested. We walk through the whole story, from controversial observational studies to where the evidence stands today.
Related articles
PoradnikiTRT or Lifestyle Change? What Actually Raises Testosterone Before You Consider Therapy
Before considering testosterone replacement therapy, it's worth checking how much sleep, training, and fat loss can realistically achieve — and when these interventions genuinely aren't enough.
July 29, 2026
PoradnikiTRT and Fertility: Can Testosterone Therapy Cause Infertility?
Testosterone replacement therapy can suppress sperm production even in men with a 'perfect' blood testosterone result — we explain the mechanism, the real scale of the problem, and the concrete options for men who want to have children.
August 15, 2026
PoradnikiTRT and Sleep — Can Testosterone Improve Sleep Quality?
Poor sleep lowers testosterone — that's well documented. But does raising testosterone with replacement therapy improve sleep the other way around? The evidence is much weaker than for other TRT effects, and in some men therapy can actually worsen sleep apnea — so before asking "will it help me sleep," it's worth first asking whether untreated apnea might be the actual source of low testosterone.
August 15, 2026
PoradnikiLow Testosterone After 40 — Normal Aging or a Problem Worth Treating?
Testosterone in a forty-something man genuinely can be lower than it was at 25 — but "that's normal for your age" isn't an answer in itself. We explain how to tell a mild, expected decline apart from a situation that deserves proper testing and a real decision.
August 15, 2026
Comments (2)
- KW
Kasia W. 2 weeks ago
Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.
- MT
Marek T. a month ago
Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.